PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 5:04 AM ET

Sponsor Check › Person

EA
No photo found yet (own website and image search run after this page is viewed)

Edward Andrle

Named as an officer, director or promoter on SEC Form D filings · MN · Jun 14, 2017 → Aug 16, 2024

2deals (issuers)
$39.7Mreported sold
50investors
6Form D filings
2017–2024years on file

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:38 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Edward Andrle is listed as a director on 6 SEC Form D filings by 2 issuers between Jun 2017 and Aug 2024: Respicardia, Inc. (Minnetonka, MN — other health care — 2017; $27.2M reported sold to 14 investors) and NEUROONE MEDICAL TECHNOLOGIES Corp (Eden Prairie, MN — biotechnology — 2020–2024; $12.5M reported sold to 36 investors).

What this means 2 separate companies raised money with this person listed as director, over about 7 years. Across those companies the filings report $39.7M sold in total.

Listed alongside David A. Rosa (4 shared filings), Jeffrey S. Mathiesen (4 shared filings), Mark Christianson (4 shared filings), Paul Buckman (4 shared filings), Steve Mertens (4 shared filings) and 9 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Edward. Each name links to their own page.

1 of the issuers belongs to the sponsor group Neuroone (2 issuers, $1.8M reported sold, 2016–2024).

What this means A sponsor group is one team that sets up a new company for each deal. Neuroone has 2 companies on file and $1.8M reported sold in total — the group page shows the whole track record in one place.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 2 court cases matching the name listed in Key records below.

What this means 2 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared 6 public filings for Edward Andrle and found 4 differences: Form D filed 21 days after the first sale; No amendment in the last 12 months on an offering that may still be open; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Edward Andrle has not run yet — it is joining a line of 5,633 names; searches run around the clock at the hosts' allowed rate. Searched so far: 27 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

2 cases: 2 closed (disposition not in docket feed)

Watson v. Cobb, Olson & Andrle, LLC closed
District Court, N.D. Georgia · No. 1:22-cv-01227 · Filed Mar 28, 2022 · Closed May 20, 2022
Role of Cobb, Olson & Andrle, LLC: Defendant · Outcome: Terminated 2022-05-20 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same rare surname (2 people in Form D filings, 2 federal dockets); surname only in the caption; court in GA (not a filing state)
Newgo v. Cobb, Olson & Andrle llc. closed
District Court, N.D. Georgia · No. 1:21-cv-02218 · Filed May 26, 2021 · Closed Aug 18, 2021 · Nature of suit: 220 Real Property: Foreclosure · Cause: 15:1692 Fair Debt Collection Act
Role of Cobb, Olson & Andrle llc.: Defendant · Outcome: Terminated 2021-08-18 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same rare surname (2 people in Form D filings, 2 federal dockets); surname only in the caption; court in GA (not a filing state)
What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:38 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: AZ, CA, DE, TX, WA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Edward Andrle..

State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states are not covered.

3. Bankruptcies

None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:38 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

4 differences found between the filings for Edward Andrle (compared 6 filings on Oct 24, 2026)

Note · May 24, 2017 – Jun 14, 2017

Form D filed 21 days after the first sale — Respicardia, Inc.

The filing says the first sale was May 24, 2017. The Form D was filed Jun 14, 2017 — 21 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 6 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Sources
Note · Apr 30, 2020 – May 14, 2020

No amendment in the last 12 months on an offering that may still be open — NEUROONE MEDICAL TECHNOLOGIES Corp (latest filing May 14, 2020)

The latest filing for this offering is dated May 14, 2020 (first sale Apr 30, 2020). It reports $2,469,800 sold of $6,000,000 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Sources
Note · Dec 4, 2017 – Dec 18, 2017

No amendment in the last 12 months on an offering that may still be open — Respicardia, Inc. (latest filing Dec 18, 2017)

The latest filing for this offering is dated Dec 18, 2017 (first sale Dec 4, 2017). It reports $20,000,000 sold of $40,000,000 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Sources
Note · May 24, 2017 – Jun 14, 2017

No amendment in the last 12 months on an offering that may still be open — Respicardia, Inc. (latest filing Jun 14, 2017)

The latest filing for this offering is dated Jun 14, 2017 (first sale May 24, 2017). It reports $5,122,000 sold of $6,622,000 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

3 of 6 offerings report sales commissions totalling $2,235,000; 0 report finder's fees; 2 report proceeds to related persons totalling $2,293,000. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Aug 16, 2024 D
NEUROONE MEDICAL TECHNOLOGIES Corp
File 021-521739
$0$0$0None listed on this filingEDGAR ↗
Jan 27, 2021 D
NEUROONE MEDICAL TECHNOLOGIES Corp
File 021-387551
$1,000,000 (est.)$0$1,350,000 (est.)The Benchmark Company, LLC BrokerCheck CRD 22982 ↗EDGAR ↗
Aug 10, 2020 D
NEUROONE MEDICAL TECHNOLOGIES Corp
File 021-372833
$0$0$0None listed on this filingEDGAR ↗
May 14, 2020 D
NEUROONE MEDICAL TECHNOLOGIES Corp
File 021-366917
$360,000 (est.)$0$943,000 (est.)
The proceeds of this private placement, along with proceeds from other financings, may be used to pay certain executive officers and directors.
Paulson Investment Company BrokerCheck CRD 5670 ↗EDGAR ↗
Dec 18, 2017 D
Respicardia, Inc.
File 021-300972
$875,000$0$0Piper Jaffray & Co. BrokerCheck CRD 665 ↗EDGAR ↗
Jun 14, 2017 D
Respicardia, Inc.
File 021-288686
$0$0$0None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 2

Every issuer that named Edward Andrle on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

Biotechnology · group: Neuroone

NEUROONE MEDICAL TECHNOLOGIES Corp

Eden Prairie, MN · May 14, 2020 → Aug 16, 2024 · 4 filings
  • Aug 16, 2024 · D · $276,043 sold of $276,043 · 20 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 27, 2021 · D · $12,500,000 sold of $12,500,000 · 36 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 10, 2020 · D · $135,000 sold of $135,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 14, 2020 · D · $2,469,800 sold of $6,000,000 · 33 investors · min. $25,000 · role: Director EDGAR ↗

Raised $12.5M from 36 investors (100% of the $276K target) as of the latest filing. Edward is listed as director on 4 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other Health Care

Respicardia, Inc.

Minnetonka, MN · Jun 14, 2017 → Dec 18, 2017 · 2 filings
  • Dec 18, 2017 · D · $20,000,000 sold of $40,000,000 · 13 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 14, 2017 · D · $5,122,000 sold of $6,622,000 · 13 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $27.2M from 14 investors (68% of the $40M target) as of the latest filing. Edward is listed as director on 2 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

People around Edward 14

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.

DR
No photo found yet (own website and image search run after this page is viewed)
Person

David A. Rosa

Executive Officer, Director · 4 shared filings (1 issuer) · also on 5 other issuers

David A. Rosa is on 6 issuers in total — a repeat sponsor. Their page lists every one.

PB
No photo found yet (own website and image search run after this page is viewed)
Person

Paul Buckman

Director · 4 shared filings (1 issuer) · also on 10 other issuers

Paul Buckman is on 11 issuers in total — a repeat sponsor. Their page lists every one.

JM
No photo found yet (own website and image search run after this page is viewed)
Person

Jeffrey S. Mathiesen

Director · 4 shared filings (1 issuer) · also on 4 other issuers

Jeffrey S. Mathiesen is on 5 issuers in total — a repeat sponsor. Their page lists every one.

MC
No photo found yet (own website and image search run after this page is viewed)
Person

Mark Christianson

Executive Officer · 4 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Edward Andrle. Their page shows their other deals.

SM
No photo found yet (own website and image search run after this page is viewed)
Person

Steve Mertens

Executive Officer · 4 shared filings (1 issuer)

Listed on the same filings as Edward Andrle. Their page shows their other deals.

RM
No photo found yet (own website and image search run after this page is viewed)
Person

Ronald McClurg

Executive Officer · 2 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Edward Andrle. Their page shows their other deals.

WJ
No photo found yet (own website and image search run after this page is viewed)
Person

Wilfred Jaeger

Director · 2 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Edward Andrle. Their page shows their other deals.

BJ
No photo found yet (own website and image search run after this page is viewed)
Person

B. Kristine Johnson

Director · 2 shared filings (1 issuer) · also on 4 other issuers

B. Kristine Johnson is on 5 issuers in total — a repeat sponsor. Their page lists every one.

BL
No photo found yet (own website and image search run after this page is viewed)
Person

Bonnie Labosky

Executive Officer, Director · 2 shared filings (1 issuer)

Listed on the same filings as Edward Andrle. Their page shows their other deals.

TH
No photo found yet (own website and image search run after this page is viewed)
Person

Timothy Hauch

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Edward Andrle. Their page shows their other deals.

TW
No photo found yet (own website and image search run after this page is viewed)
Person

Thomas Weldon

Director · 2 shared filings (1 issuer) · also on 4 other issuers

Thomas Weldon is on 5 issuers in total — a repeat sponsor. Their page lists every one.

WA
No photo found yet (own website and image search run after this page is viewed)
Person

William Abraham

Director · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Edward Andrle. Their page shows their other deals.

KN
No photo found yet (own website and image search run after this page is viewed)
Person

Kirk Nielsen

Director · 2 shared filings (1 issuer) · also on 24 other issuers

Kirk Nielsen is on 25 issuers in total — a repeat sponsor. Their page lists every one.

CV
No photo found yet (own website and image search run after this page is viewed)
Person

Christopher Volker

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Edward Andrle. Their page shows their other deals.

The team behind the deals

Sponsor group

Neuroone

2 issuers · 18 filings · $1.8M reported sold · 2016–2024

One team, 2 deal companies. Edward Andrle is listed on 1 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Edward Andrle.

Same business address

1 other issuer file from the same address

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Adviser registration (Form ADV)

None of the 2 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Edward Andrle by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 2 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Edward Andrle is listed on: none on file. No website or social profile named in Respicardia, Inc.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #262,862 of 374,652 in line (14 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Minnetonka, MN). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Edward Andrle appears on a new Form D, or when a court case or SEC action is matched to them. See plans →